pillbase.ru

JANUMET

Active substance: SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE

TABLET, FILM COATED · SITAGLIPTIN PHOSPHATE 50 mg/1, METFORMIN HYDROCHLORIDE 1000 mg/1

United StatesActive

Marketing holder: A-S Medication Solutions

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing sitagliptin in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 51
  • Асиглия®
    таблетки, покрытые пленочной оболочкой, 100 мг (original in Russian, GRLS)
    ЛП-№(000655)-(РГ-RU)
    АО "КРКА, д.д., Ново место"
  • Асиглия® Мет
    таблетки, покрытые пленочной оболочкой, 850 мг+50 мг (original in Russian, GRLS)
    ЛП-№(000695)-(РГ-RU)
    АО "КРКА, д.д., Ново место"
  • Велметия®
    таблетки, покрытые пленочной оболочкой, 850 мг+50 мг (original in Russian, GRLS)
    ЛП-№(012814)-(РГ-RU)
    Берлин-Хеми АГ
  • Велметия®
    таблетки, покрытые пленочной оболочкой, 850 мг+50 мг (original in Russian, GRLS)
    ЛП-004547
    Берлин-Хеми АГ
  • Гиксинтрик
    таблетки, покрытые пленочной оболочкой, 100 мг (original in Russian, GRLS)
    ЛП-№(006673)-(РГ-RU)
    Общество с ограниченной ответственностью "МАКИЗ-ФАРМА" (ООО "МАКИЗ-ФАРМА")
All products in this country (51)
EU 14
  • Efficib
    sitagliptin, metformin hydrochloride
    EMEA/H/C/000896
    Merck Sharp and Dohme B.V
  • Janumet
    sitagliptin, metformin hydrochloride
    EMEA/H/C/000861
    Merck Sharp & Dohme B.V.
  • Januvia
    sitagliptin
    EMEA/H/C/000722
    Merck Sharp and Dohme B.V
  • Ristaben
    sitagliptin
    EMEA/H/C/001234
    Merck Sharp & Dohme B.V.
  • Ristfor
    sitagliptin, metformin hydrochloride
    EMEA/H/C/001235
    Merck Sharp & Dohme B.V.
All products in this country (14)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-378a-752b-ba2c-f52ee52b6b17,01a120c3-37a6-77c8-8bdf-c65c1cf26623,01a120c3-389d-7ad8-8c3f-e52c5376d328,01a120c3-38e6-7870-9fe1-e62bdd6d25f7,01a120c3-49c6-7464-a5fe-bfcbfabd743e;count=27 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-bcc4-799b-b9cd-0ac4e9a2829e,01a1208c-e836-7876-8ac0-31252f07f1c1,01a1208d-5621-7533-a73b-cd65fca7ed17,01a1208d-a84b-7eb3-9de2-8740f40900f0,01a1208f-55b8-7a49-9744-a8da0e37bbb3;count=36 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50090-5502
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 50090-5502 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50090-5502 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50090-5502 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 50090-5502 · Verified 2026-10-09 · open in source